According to Philips, a product-development programme is underway and the first milestone is expected in 2010. As part of the agreement, Biomérieux will have access to Philips’ proprietary Magnotech technology for hospital-based point-of-care testing applications, a market that is said to be growing at 10 per cent a year.
Products resulting from the partnership will be co-branded by Philips and Biomérieux, with Biomérieux being the exclusive distributor worldwide. The two companies intend to have products on the market by 2013.
‘Philips is convinced that point-of-care testing in hospital critical-care settings will play a major part in improving patient outcomes and reducing healthcare costs,’ said Steve Rusckowski, executive vice president and chief executive officer, Philips Healthcare.
Promoted content: Does social media work for engineers – and how can you make it work for you?
So in addition to doing their own job, engineers are expected to do the marketing department´s work for them as well? Sorry, wait a minute, I know the...